google-site-verification: googlec7193c3de77668c9.html

Monoclonal antibody shows promising results for rare liver disease

[
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and anti-fibrotic monoclonal antibody known as nebokitug was safe and showed potential efficacy in patients with PSC.


Source link

Advertisements
Views: 0

See also  Understanding a broken heart—study finds link between stress and recurrent heart failure

Check Also

P0g0gjs2.jpg

What in the World – Why are more young people being diagnosed with cancer?

Available for over a year According to the World Health Organisation, around 1 in 5 …

Research confirms Rx Kids improved outcomes for Flint babies, families

[ Credit: Laura Garcia from Pexels A study published in The Lancet Public Health found …

Why renaming my health condition could help other women

Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS. …

Leave a Reply

Available for Amazon Prime